The article is devoted to classification of thyroid diseases.

The article is devoted to the IVth All-Russian Congress of Endocrinologists.

The article is devoted to identification of genetic markers coupled with type 1 diabetes mellitus.

The article is devoted the prevalence of thyroid cancer.

The article is devoted to genetic aspects of thyroid cancer.

The article is devoted to modern aspects of monitoring patients with differentiated thyroid cancer.

The article is devoted to locus of control in diabetics. 

The article is devoted to coagulation signs of endothelial stress in patients with type 2 diabetes mellitus concomitant with arterial hypertension.

The article is devoted to evaluation of bone tissue status in patients with diabetic foot.

The article is devoted to endocrine disrupters and reproductive health.

The article is devoted to differential diagnosis and choice of passport sex in patients with false male hermaphroditism.

The article is devoted to psychosexual rehabilitation of patients with false male hermaphroditism.

The article is devoted to functional bivalence of estrogens and estrogen effect switching over.

Multidose injection syringe pen "Genotropin Pen 5.3" for subcutaneous injections of recombinant human growth hormone (HGH) was evaluated in 15 patients with somatotropic insufficiency using special questionnaires. The pen proved to be convenient, its new design with an extra cap covering the needle during injection helps reduce the fear and discomfort during injection. The pen is safe and simple to use and is recommended for the treatment of patients with somatotropic insufficiency.

Russian drug glydiab (Akrikhin, Russia) regulates basal and postprandial glycemia, glycated hemoglobin, and C peptide, normalizes lipid metabolism, arterial pressure, body weight, and lipid peroxidation in 82% patients with type 2 diabetes mellitus. An important clinical and pathogenetic characteristic of glydiab is prevention of excessive insulin production. Presumably, activation of antioxidant defense leads to improvement of insulin receptor interactions and insulin sensitivity. Glydiab is easy to use, well tolerated, easily available, and is recommended for the treatment of patients with type 2 diabetes mellitus.